Effect of Nurse-led Education on Parent's Anxiety and Depression on Managing Side Effects of Chemotherapy
1 other identifier
interventional
100
1 country
1
Brief Summary
ABSTRACT Background: Today, a wide range of pediatric cancers is treated by chemotherapy. More than 21 side effects of chemotherapy have been identified. Among those nausea; vomiting, infection and anemia are most common. The adverse effects are normally managed by the parents at home. Ineffective coping and lack of knowledge about chemotherapy side effect management leads parents stress. Contemporary research evidence that Nurse-led education, booklet providence and follow up about chemotherapy and side effect management, help to decrease parents anxiety and depression. Objectives: To measure the effect of nurse-led multimedia education, booklet providence and telephonic follow up about chemotherapy and side effects management on parents anxiety and depression of children receiving chemotherapy for the first time. Methodology: A randomized control trial will be conducted in the department of chemotherapy at Indus Children Cancer Hospital Karachi from March 2018 to August 2018 on parents of children below 18 years of age undergoing chemotherapy for the first time. Total 100 parents will be randomly divided into Intervention group (n=50) and Control Group (n=50). The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management. The Control group will receive routine care. Parent's anxiety and depression will be identified by using DASS-21 and generalized estimating estimation will be used to analyzed the data. Keywords: Nurse-led, Multimedia education, Booklet, telephonic follow-up, chemotherapy, side effects, parents, anxiety, depression, children, cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 6, 2018
CompletedFirst Submitted
Initial submission to the registry
November 16, 2018
CompletedFirst Posted
Study publicly available on registry
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2019
CompletedResults Posted
Study results publicly available
July 28, 2022
CompletedJuly 28, 2022
July 1, 2022
4 months
November 16, 2018
August 6, 2019
July 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depression, Anxiety and Stress Scale - 21 (DASS-21)
DASS-21 is comprised of questionnaires for three separate scales measuring Depression, Anxiety and Stress. The depression scale is scored by summing the responses of each question, multiplying by 2 and then scoring on a scale ranging from a minimum of 0 to a maximum of 28+, with higher scores indicating greater severity. The anxiety scale is scored by summing the responses of each question, multiplying by 2 and then scoring on a scale ranging from a minimum of 0 to a maximum of 20+, with higher scores indicating greater severity. The stress scale is scored by summing the responses of each question, multiplying by 2 and then scoring on a scale ranging from a minimum of 0 to a maximum of 37+, with higher scores indicating greater severity
up to 4 weeks
Study Arms (2)
Intervention
EXPERIMENTALThe Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management
Control
NO INTERVENTIONThe Control group will receive routine care
Interventions
Multimedia education, booklet and weekly tele-nursing follow-up is about chemotherapy and side effects management
Eligibility Criteria
You may qualify if:
- Parents along with their children newly diagnosed with cancer in last three weeks
- Parents along with their children schedule to receive first time chemotherapy in the outpatient department
You may not qualify if:
- Parents along with their children refused to participate
- Parents along with their children already receiving interventions like multimedia education, booklet providence and telephonic follow up for chemotherapy and side effect management
- Parents taking medicine for their anxiety and depression. (e.g. Anxiolytics/ Antidepressant)
- Parents showing uneasiness and discomfort during educational session.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nomi Waqas Gullead
- Indus Hospital and Health Networkcollaborator
Study Sites (1)
Indus Children Cancer Hospital Karachi
Karachi, Sindh, Pakistan
Related Publications (25)
Bhurgri Y, Bhurgri A, Nishter S, Ahmed A, Usman A, Pervez S, Ahmed R, Kayani N, Riaz A, Bhurgri H, Bashir I, Hassan SH. Pakistan--country profile of cancer and cancer control 1995-2004. J Pak Med Assoc. 2006 Mar;56(3):124-30. No abstract available.
PMID: 16696512BACKGROUNDAshraf MS. Pediatric oncology in Pakistan. J Pediatr Hematol Oncol. 2012 Mar;34 Suppl 1:S23-5. doi: 10.1097/MPH.0b013e318249abf9.
PMID: 22357147BACKGROUNDCCHK. Children cancer Hospital karachi. 2017 [cited 2017; Available from: http://ccfpakistan.org/.
BACKGROUNDKlein CA. Cancer. The metastasis cascade. Science. 2008 Sep 26;321(5897):1785-7. doi: 10.1126/science.1164853. No abstract available.
PMID: 18818347BACKGROUNDMansoor, S. and S. Jehangir, Anxiety, depression in patient receving chemotherapy for solid tumors. Pak Armed Forces Med. J, 2015. 65(1): p. 89-93.
BACKGROUNDIqbal A, Siddiqui KS. Depression among parents of children with acute lymphoblastic leukemia. J Ayub Med Coll Abbottabad. 2002 Apr-Jun;14(2):6-9.
PMID: 12238347BACKGROUNDBorsellino M, Young MM. Anticipatory coping: taking control of hair loss. Clin J Oncol Nurs. 2011 Jun;15(3):311-5. doi: 10.1188/11.CJON.311-315.
PMID: 21624866BACKGROUNDGraca Pereira M, Figueiredo AP, Fincham FD. Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: A study with Portuguese patients and their partners. Eur J Oncol Nurs. 2012 Jul;16(3):227-32. doi: 10.1016/j.ejon.2011.06.006. Epub 2011 Jul 23.
PMID: 21783416BACKGROUNDPouresmail, Z., S. Sharafi, and M. Razi, The Role of Evidence Based Nursing in Prevention of Gastrointestinal Side Effects of Chemotherapy in Children with Cancer. International Journal of Pediatrics, 2014. 2(2.1): p. 48-48
BACKGROUNDMohammed, H.A., Impact of proposed nursing rehabilitation program on self management of selected side effects of chemotherapy for elderly patints with gastrointestinal cancer. CU Theses, 2012.
BACKGROUNDMunir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs. 2010 May;19(9-10):1362-70. doi: 10.1111/j.1365-2702.2009.03006.x.
PMID: 20500346BACKGROUNDGarcia S. The effects of education on anxiety levels in patients receiving chemotherapy for the first time: an integrative review. Clin J Oncol Nurs. 2014 Oct;18(5):516-21. doi: 10.1188/14.CJON.18-05AP.
PMID: 25164233BACKGROUNDHoon LS, Chi Sally CW, Hong-Gu H. Effect of psychosocial interventions on outcomes of patients with colorectal cancer: a review of the literature. Eur J Oncol Nurs. 2013 Dec;17(6):883-91. doi: 10.1016/j.ejon.2013.05.001. Epub 2013 Jun 4.
PMID: 23759360BACKGROUNDLerdkiattikorn, P., et al., Quality of life among stage III colon cancer patients receiving oral and intravenous chemotherapy regimens in Thailand. Mahidol University Journal of Pharmaceutical Sciences, 2012. 39: p. 41-3.
BACKGROUNDKutlu, R., et al., Kanserli hastalarda depresyon ve yaşam kalitesini etkileyen faktörler. Selçuk Üniv Tıp Derg, 2011. 27(3): p. 149-153
BACKGROUNDGullatte M. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy safety standards. J Oncol Pract. 2013 Mar;9(2 Suppl):3s-4s. doi: 10.1200/JOP.2012.000862.
PMID: 24135010BACKGROUNDNetwork, N.C.C. Distress management. In NCCN Clinical Practice Guidelines in Oncology. . 2017; Available from: http://www.nccn.org.
BACKGROUNDLeighl N, Gattellari M, Butow P, Brown R, Tattersall MH. Discussing adjuvant cancer therapy. J Clin Oncol. 2001 Mar 15;19(6):1768-78. doi: 10.1200/JCO.2001.19.6.1768.
PMID: 11251008BACKGROUNDWilliams SA, Schreier AM. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncol Nurs Forum. 2004 Jan-Feb;31(1):E16-23. doi: 10.1188/04.ONF.E16-E23.
PMID: 14722602BACKGROUNDYasin, Y.M. and A. Al-Hamad, ANXIETY AND DEPRESSION AS KEY DETERMINANTS OF CANCER RELATED FATIGUE AMONG PATIENTS RECEIVING CHEMOTHERAPY. European Scientific Journal, ESJ, 2015. 11(33)
BACKGROUNDManir KS, Bhadra K, Kumar G, Manna A, Patra NB, Sarkar SK. Fatigue in breast cancer patients on adjuvant treatment: course and prevalence. Indian J Palliat Care. 2012 May;18(2):109-16. doi: 10.4103/0973-1075.100826.
PMID: 23093826BACKGROUNDHeidari H, Hasanpour M, Fooladi M. The experiences of parents with infants in Neonatal Intensive Care Unit. Iran J Nurs Midwifery Res. 2013 May;18(3):208-13.
PMID: 23983756BACKGROUNDHaugan G, Drageset J. The hospital anxiety and depression scale--dimensionality, reliability and construct validity among cognitively intact nursing home patients. J Affect Disord. 2014 Aug;165:8-15. doi: 10.1016/j.jad.2014.04.042. Epub 2014 Apr 24.
PMID: 24882171BACKGROUNDSarafraz Nasab, M. and M. Mojtabaie, P116: Reminiscence Therapy Efficacy in Reducing Symptoms of Anxiety in Elderly Nursing Home Residents in Tehran. The Neuroscience Journal of Shefaye Khatam, 2014. 2(3): p. 140-140.
BACKGROUNDZakerimoghadam, M., S. Ghiasvandian, and P. Salahshoor, The effect of supportive nursing program on depression, anxiety and stress of family members of patients during coronary artery bypass graft (CABG) surgery. Iranian Journal of Cardiovascular Nursing, 2014. 3(1): p. 50-58
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
As the study was conducted in single setting, hence the result may not be generalized. Further studies are recommended to measure its general effect.
Results Point of Contact
- Title
- Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi
- Organization
- Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi
Study Officials
- STUDY CHAIR
Dr. Mehwish HUSSAIN, PhD (Statistics)
Assistant Professor, DUHS, Karachi
- STUDY CHAIR
Dr. SHAMVIL ASHRAF, MBBS, DCH, MCPS, FCPS, MRCP
Indus Hospital Karachi
- STUDY CHAIR
Mr. Hakim Shah, MSN
Associate Professor Institute of Nursing Dow University of Health Sciences Karachi
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 16, 2018
First Posted
November 27, 2018
Study Start
September 6, 2018
Primary Completion
December 30, 2018
Study Completion
June 15, 2019
Last Updated
July 28, 2022
Results First Posted
July 28, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share
No plan